Filing Flows

Filing Flows › Cytek Biosciences (CTKB) › How it makes money

How Cytek Biosciences (CTKB) makes money

Cytek Biosciences (CTKB) made $53.2M of revenue in the third quarter 2026 (Q3 2026), +2% from a year earlier. Product brought in $37.2M (70%); Service brought in $16.1M (30%).

Drawing the Sankey…

Cytek Biosciences revenue by segment, Q3 2026Cytek Biosciences revenue by segment, Q3 2026Product$37.2MService$16.1M
Cytek Biosciences: revenue by line, Q1 2025 to Q3 2026Cytek Biosciences: revenue by line, Q1 2025 to Q3 2026ProductServiceProduct: $37.2M latest$37.2MService: $16.1M latest$16.1MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Service went from 32% of revenue in Q1 2025 to 30% in Q3 2026, the largest shift in the mix.
Cytek Biosciences revenue by quarterCytek Biosciences revenue by quarter$41.5MQ1 2025$45.6MQ2 2025$52.3MQ3 2025$62.1MQ4 2025$44.1MQ1 2026$48.1MQ2 2026$53.2MQ3 2026

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Product$37.2M69.8%+14%-3%
Service$16.1M30.2%+3%+13%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$53.2M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$53.2M+2%
Q2 2026$48.1M+6%
Q1 2026$44.1M+6%
Q4 2025$62.1M+8%
Q3 2025$52.3M+2%
Q2 2025$45.6M-2%
Q1 2025$41.5M-8%

From Cytek Biosciences' 10-Q filed Nov 4, 2026 (on EDGAR).

Questions

How does Cytek Biosciences make money?

Cytek Biosciences (CTKB) made $53.2M of revenue in the third quarter 2026 (Q3 2026), +2% from a year earlier. Product brought in $37.2M (70%); Service brought in $16.1M (30%).

What is Cytek Biosciences' biggest business?

Product: $37.2M in the third quarter 2026, 70% of revenue, -3% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.